◆ 会议时间：2023年9月8-9日
◆ 会议地点：马来西亚 吉隆坡

◆ 会议简介：

2023年第16届亚太动脉粥样硬化与血管疾病学会(APSAVD)大会将于2023年9月8-9日在马来西亚吉隆坡 举行，本次会议将汇集科学家、医疗工作者、政策制定者和所有对动脉粥样硬化感兴趣的相关人士。

亚太动脉粥样硬化与血管疾病学会(APSAVD成立于1996年，其宗旨是为该地区对动脉粥样硬化感兴趣的科学家和临床医生提供一个分享交流宣有关该领域最新信息的论坛。未经本站许可禁止复制转载镜像本站任何内容—领域国际医学会议网(lingyuint.com)。

16th Asian Pacific Society of Atherosclerosis and Vascular Disease Congress 2023

Date: September 8 - 9, 2023
Venue: Connexion Conference & Event Centre (CCEC) 

Organised By：
Malaysian Society of Atherosclerosis (MSA)
National Heart Association of Malaysia (NHAM)
Asian-Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD)

Welcome Message From Congress Chair

Welcome to the 16th Asian Pacific Society of Atherosclerosis and Vascular Disease Congress 2023! We are thrilled to bring together an esteemed group of medical professionals, researchers, and industry leaders to share the latest advancements and research in the field of atherosclerosis and vascular disease. This congress will provide an opportunity for attendees to gain a deeper understanding of the challenges and opportunities in the prevention, diagnosis, and treatment of these conditions.

This congress will feature presentations and discussions on the latest scientific breakthroughs, clinical trial results, and best practices in the field. Attendees will also have the opportunity to network with experts in the field, share knowledge and ideas, and learn from one another.

We are honoured to host this event and are committed to providing an environment that is conducive to learning, growth, and progress. Our goal is to foster an open and inclusive atmosphere where attendees can feel comfortable sharing their ideas and experiences.

We hope that you find the sessions informative and engaging and that you leave with a deeper understanding of the challenges and opportunities in this important area of medicine. Thank you for joining us and we look forward to a productive and enlightening congress.

Ahmad Syadi Mahmood Zuhdi
Congress Chair
APSAVD 2023

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。